5/5/2024 | 11:30 AM – 12:45 PM | Exhibit Hall F1
Poster Session—Novel Strategies in CAR T Therapies (AM)
Activation of APOBEC3B and Induced APOBEC3 Mutations in Self-Inactivating Lentiviral-Based CAR T Cell Production Decreases the Efficiency of CAR T Cell Production
(P519)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 519
Abstract ID: 4781
Presenting Author:
Jack Swanson, Mayo Clin. Grad. Sch. of Biomed. Sci., Mayo Clin., Minnesota
Co-Authors:
Jason Tonne, Mayo Clin., Minnesota; Richard Vile, Mayo Clin., Minnesota;
View Abstract Details
Novel tumor-specific Vδ1/3 γδ CAR T cells effectively control solid tumors
(P521)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 521
Abstract ID: 4696
Presenting Author:
Luis U Lopez Bailon, Duke Cancer Inst., Duke Univ. Sch. of Med.
Co-Authors:
Carmen M Anadon, Duke Cancer Inst.; Ricardo A Chaurio, Duke Cancer Inst.; Jessica A Mine, Duke Univ. Sch. of Med.; Noah Plappert, Duke Univ. Sch. of Med.; Scott Antonia, Duke Cancer Inst.; Jose R Conejo-Garcia, Duke Univ. Sch. of Med.;
View Abstract Details
Molecular and epigenetic mechanisms by which stat5 regulates polyfunctionality in antitumor cd4+ T cells.
(P525)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 525
Abstract ID: 5430
Presenting Author:
Ogacheko D Okoko, Georgia Cancer Ctr.. Augusta Univ.
Co-Authors:
Md Yeashin Gazi, Georgia Cancer Ctr.. Augusta Univ.; Mercy Kehinde-Ige, Georgia Cancer Ctr.. Augusta Univ.; Xin Wang, Augusta Univ.; Caitlin Brandle, Med. Col. of Georgia, Augusta Univ.; Huidong Shi, Georgia Cancer Ctr.. Augusta Univ.; Gang Zhou, Georgia Cancer Ctr.. Augusta Univ.;
View Abstract Details
Enrichment using a selectable CD34t marker enhances TCR/CAR transduced T cell functionality and transgene expression in clinically relevant receptors
(P527)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 527
Abstract ID: 5872
Presenting Author:
Suzanne Quinn, Loyola Univ. Chicago
Co-Authors:
Gina M Scurti, Loyola Univ. Chicago; Annika V Dalheim, Loyola Univ. Chicago; Oliwia Bochnacka, Loyola Univ. Chicago; Nasheed M Hossain, Loyola Univ. Chicago; Michael I Nishimura, Loyola Univ. Chicago;
View Abstract Details
Mechanistic investigations of a TLR4 adjuvant effects on γ9δ2 T cells.
(P529)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 529
Abstract ID: 5918
Presenting Author:
Kathleen Phelps, Saint Louis Univ. Sch. of Med.
Co-Authors:
Mei Xia, Saint Louis Univ. Sch. of Med.; Christopher Fox, Infectious Dis. Res. Inst.; Nikolai Petrovsky, Vaxine; Darrick Carter, PAI Life Sci.; Daniel Hoft, Saint Louis Univ. Sch. of Med.;
View Abstract Details
Strategies for Comprehensive Immune Monitoring of Clinical Trials to Advance Human Immunotherapy in Remote Settings
(P531)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 531
Abstract ID: 5841
Presenting Author:
Jessica Watson, Standard BioTools
Co-Authors:
Natalie Smith, Univ. of Sydney; Michael Cohen, Standard BioTools; Julie Alipaz, University of Sydney; Christina Loh, Standard BioTools; David King, Standard BioTools; Barbara Fazekas de St Groth, Univ. of Sydney; Helen McGuire, Univ. of Sydney;
View Abstract Details
Targeting CD38 and CD138 Antigens through NK Cell Immunotherapy for Effective Treatment of Multiple Myeloma
(P533)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 533
Abstract ID: 4906
Presenting Author:
Seung-Hwan Lee, Univ. Ottawa
Co-Authors:
Dong-Hyeon Jo, Univ. Ottawa; Shelby Kaczmarek; Safa Ghaziasgar, Univ. Ottawa; Oksu Shin, Univ. Ottawa; Joy Shin, Univ. Ottawa; Juthaporn Cowan, Ottawa Hosp. Res. Inst.; Scott McComb, Natl. Res. Cou. Canada; Alissa Visram, Ottawa Hosp. Res. Inst.;
View Abstract Details
CAR T cells against TRP1 significantly reduce melanoma growth in vitro and in vivo
(P535)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 535
Abstract ID: 4687
Presenting Author:
Justin C Boucher, Moffitt Cancer Ctr.
Co-Authors:
Anna L Austin, Moffitt Cancer Ctr.; Elena Kostenko, Moffitt Cancer Ctr.; Jose A Guevara-Patino, Moffitt Cancer Ctr.;
View Abstract Details